HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pharmacokinetic study of neural stem cell-based cell carrier for oncolytic virotherapy: targeted delivery of the therapeutic payload in an orthotopic brain tumor model.

Abstract
Oncolytic virotherapy is a promising novel therapy for glioblastoma that needs to be optimized before introduced to clinic. The targeting of conditionally replicating adenoviruses (CRAds) can be improved by relying on the tumor-tropic properties of neural stem cells (NSCs). Here, we report the characterization of an FDA approved NSC, HB1.F3-CD, as a cell carrier for CRAd-S-pk7, a glioma-tropic oncolytic adenovirus. We show that NSCs replicate and release infectious CRAd-S-pk7 progeny capable of lysing glioma cell lines. Moreover, ex-vivo-loaded NSCs, injected intracranially in nude mice bearing human glioma xenografts (i) retained their tumor tropism, (ii) continued to replicate CRAd-S-pk7 for more than a week after reaching the tumor site and (iii) successfully handed off CRAd-S-pk7 to glioma cells in vivo. Delivery via carrier cells reduced non-specific adenovirus distribution in the mouse brain. Moreover, we assessed biodistribution of loaded NSCs after intracranial injection in animal models semi-permissive to adenovirus replication, the Syrian hamster and cotton rat. NSCs did not migrate to distant organs and high levels of CRAd-S-pk7 DNA were observed only in the injected hemisphere. In conclusion, this optimized carrier system, with high efficiency of adenovirus delivery and minimal systemic toxicity, poses considerable advantages for anti-glioma oncolytic virotherapy.
AuthorsB Thaci, A U Ahmed, I V Ulasov, A L Tobias, Y Han, K S Aboody, M S Lesniak
JournalCancer gene therapy (Cancer Gene Ther) Vol. 19 Issue 6 Pg. 431-42 (Jun 2012) ISSN: 1476-5500 [Electronic] England
PMID22555507 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Adenovirus E1A Proteins
  • Recombinant Proteins
  • Green Fluorescent Proteins
  • Luciferases, Firefly
Topics
  • Adenoviridae (genetics, physiology)
  • Adenovirus E1A Proteins (biosynthesis, genetics)
  • Animals
  • Brain (pathology, virology)
  • Brain Neoplasms (therapy)
  • Cell Line
  • Cell Survival
  • Cricetinae
  • Disease Models, Animal
  • Glioma (therapy)
  • Green Fluorescent Proteins (biosynthesis)
  • Humans
  • Luciferases, Firefly (biosynthesis)
  • Male
  • Mice
  • Mice, Nude
  • Neoplasm Transplantation
  • Neural Stem Cells (transplantation)
  • Oncolytic Virotherapy (methods)
  • Oncolytic Viruses (genetics, physiology)
  • Organisms, Genetically Modified
  • Recombinant Proteins (biosynthesis)
  • Sigmodontinae
  • Viral Load
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: